Adaptive Biotechnologies Corp.
What's It Like to Work at Adaptive Biotechnologies Corp. in Seattle?
This page summarizes recurring themes identified from responses generated by popular LLMs to common candidate questions about Adaptive Biotechnologies Corp. and has not been reviewed or approved by Adaptive Biotechnologies Corp..
What's it like to work at Adaptive Biotechnologies Corp.?
Strengths in mission‑driven, clinic‑proximate science and well‑resourced Seattle facilities are accompanied by headwinds from restructuring, partner shifts, and market‑level pay competitiveness. Together, these dynamics suggest the Seattle office offers high‑impact, collaborative work with solid benefits, while requiring comfort with change and pragmatic expectations on stability and compensation.
Key Insight for Candidates
Seattle’s integrated lab–office HQ runs like a CLIA/FDA clinical shop, not a generic tech office. This means on‑site, cross‑functional work with lab, QA/Reg, and clinicians, tight process discipline and documentation, and fast execution—yielding tangible patient impact and visibility.Positive Themes About Adaptive Biotechnologies Corp.
-
Mission & Purpose: Work in Seattle is closely tied to clonoSEQ and clinical diagnostics, giving teams direct line‑of‑sight to patient impact and collaboration with clinicians and the onsite CLIA/CAP lab. Feedback suggests this clinic‑proximate focus at the South Lake Union HQ is highly motivating.
-
Benefits & Perks: Seattle employees point to strong core benefits, including high employer‑paid medical coverage, DTO for exempt staff, paid parental leave, and 12 company holidays. Commuter support like company‑paid ORCA cards further anchors the local package.
-
Innovation & Products: The Seattle HQ integrates wet labs and collaborative office space, supporting cross‑functional work across immunology, NGS, bioinformatics, and growing ML/AI efforts. Partnerships and platform advances around immune‑repertoire modeling reinforce a technically ambitious environment.
Considerations About Adaptive Biotechnologies Corp.
-
Change Fatigue: At the Seattle HQ, cost‑tightening and restructuring in 2024–2025 led to shifting priorities and leaner teams, making the pace and change feel intense for some groups. This execution‑heavy culture can translate into frequent reprioritization.
-
Job Insecurity: A prior workforce reduction and the termination of a major external collaboration underscore how partner moves and portfolio refocus can alter Seattle roadmaps. These shifts have raised questions about stability for certain areas.
-
Low Compensation: Compensation in the Seattle office is described as middling for the local biotech market and varies by function and manager. Candidates are advised to benchmark carefully given this variability.
NEW
What does AI tell candidates about your employer brand?
Get your free AI reputation report today.
See AI Report
Adaptive Biotechnologies Corp. FAQs
Is This Your Company?
Claim Profile